UC Health
Skip to content
  • Healthcare
    Services
  • Patients
    & Visitors
  • Our
    Locations
  • Healthcare
    Professionals
  • Clinical
    Research
  • Careers
    & Training
  • Health
    Library
  • Find a Physician
    • Browse All Providers
  • My UC Health
  • Contact Us
  • Donate
  • Pay Bill

UC Health Media Room

Media Relations Office: media@uchealth.com
  • Articles
  • In The News
  • Press Releases
  • Success Stories
  • Video and Media
  • Media Relations

generics

UC Health Logo

Clinical Trials to Examine Generic Drugs for Epilepsy

January 9, 2013
Posted in Articles | Also tagged Antiepileptic Drugs, epilepsy, generic drugs, GlaxoSmithKline, Lamictal, lamotrigine, Michael Privitera, seizures |
  • Next Post

    Brain Tumor Center Tests Thousands of Compounds in Search of New Glioblastoma Treatment
  • Previous Post

    67 UCNI Specialists on 2013 ‘Best Doctors’ Lists
  • Share

    Share on Facebook
    Facebook
    Tweet about this on Twitter
    Twitter
    Share on Google+
    Google+
    Share on LinkedIn
    Linkedin
    Pin on Pinterest
    Pinterest
    Email this to someone
    email
  • About UC Health

    • About UC Health
    • College of Medicine
    • Community
    • Sponsorships
    • Leadership
    • Board
    • History
    • Transition of Care
    • UC Health Foundation
    • Joint Commission Accreditation
    • Quality & Safety
    • Contact Us
  • Quick Links

    • Employees & Staff
    • News / Media
    • Classes and Events
    • Careers
    • Billing & Insurance
    • Supplier Diversity & Community Engagement
    • Disclaimer
    • Statement of Privacy Practices
    • Non-Discrimination Policy
  • Connect With Us

    • Facebook
    • YouTube
    • Twitter
  • My UC Health

    Access your medical records online, anytime.

    My UC Health gives you access to portions of your electronic medical record (EMR) on a secure server.

    Click to get started.

© 2019 UC Health.
  • Quality & Safety
  • Disclaimer
  • Statement of Privacy Practices
  • Non-Discrimination Policy